Filtered By:
Drug: Acetylcysteine
Management: Healthcare Costs
This page shows you your search results in order of date.
Order by Relevance | Date
Total 1 results found since Jan 2013.
Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease.
CONCLUSIONS: In participants with chronic bronchitis or COPD, we are moderately confident that treatment with mucolytics leads to a small reduction in the likelihood of having an acute exacerbation, in days of disability per month and possibly hospitalisations, but is not associated with an increase in adverse events. There appears to be limited impact on lung function or health-related quality of life. Results are too imprecise to be certain whether or not there is an effect on mortality. Our confidence in the results is reduced by high levels of heterogeneity in many of the outcomes and the fact that effects on exacerbat...
Source: Cochrane Database of Systematic Reviews - May 19, 2019 Category: General Medicine Authors: Poole P, Sathananthan K, Fortescue R Tags: Cochrane Database Syst Rev Source Type: research
